Centella asiatica Completed Phase 2 Trials for Diabetic Neuropathies Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00608439Centella Asiatica Selected Triterpenes (CAST) for Diabetic Neuropathy